{
  "analysis_timestamp": "2025-08-07 22:13",
  "revised_target": {
    "initial_capital": 700000,
    "target_capital": 770000,
    "required_gain": 70000,
    "required_return_pct": 10.0
  },
  "moderate_strategies": [
    {
      "ticker": "MSFT",
      "strategy": "Long Calls - Earnings Play (Conservative)",
      "current_price": 420,
      "option": "Feb 21 $430 Call",
      "option_premium": 12,
      "allocation": "20% ($140K)",
      "contracts": 116,
      "catalyst": "Q2 Earnings Jan 24, Cloud growth, AI integration",
      "risk_level": "MODERATE",
      "probability": "45-55%",
      "potential_return": "15-25% if beats by 2-3%",
      "rationale": "Stable tech giant, consistent earnings beats, Azure growth"
    },
    {
      "ticker": "GOOGL",
      "strategy": "Long Calls - Earnings Recovery",
      "current_price": 185,
      "option": "Feb 21 $190 Call",
      "option_premium": 8,
      "allocation": "20% ($140K)",
      "contracts": 175,
      "catalyst": "Q4 Earnings, Search revenue, YouTube ads",
      "risk_level": "MODERATE",
      "probability": "40-50%",
      "potential_return": "20-30% on strong beat",
      "rationale": "Oversold, strong fundamentals, AI investments paying off"
    },
    {
      "ticker": "SPY",
      "strategy": "Weekly Calls - Fed/CPI Play",
      "current_price": 595,
      "option": "Weekly ATM Calls",
      "option_premium": 4,
      "allocation": "15% ($105K)",
      "contracts": "Variable weekly",
      "catalyst": "Fed meetings, inflation data, economic reports",
      "risk_level": "MODERATE",
      "probability": "35-45%",
      "potential_return": "5-8% per week compound",
      "rationale": "Market trend following, lower risk than individual stocks"
    },
    {
      "ticker": "AMD",
      "strategy": "Long Calls - AI Recovery",
      "current_price": 172,
      "option": "Mar 21 $180 Call",
      "option_premium": 11,
      "allocation": "20% ($140K)",
      "contracts": 127,
      "catalyst": "Data center growth, AI chip demand, earnings guidance",
      "risk_level": "MODERATE-HIGH",
      "probability": "40-50%",
      "potential_return": "25-40% on strong guidance",
      "rationale": "AI play with more reasonable valuation than NVDA"
    },
    {
      "ticker": "QQQ",
      "strategy": "Long Calls - Tech Momentum",
      "current_price": 569,
      "option": "Feb 21 $575 Call",
      "option_premium": 15,
      "allocation": "15% ($105K)",
      "contracts": 70,
      "catalyst": "Big tech earnings season, Fed dovish pivot",
      "risk_level": "MODERATE",
      "probability": "45-55%",
      "potential_return": "12-18% on tech rally",
      "rationale": "Diversified tech exposure, less single-stock risk"
    },
    {
      "ticker": "Cash Reserve",
      "strategy": "Hold Cash for Opportunities",
      "allocation": "10% ($70K)",
      "rationale": "Dry powder for mid-month opportunities or averaging down",
      "risk_level": "LOW",
      "potential_return": "0% but preserves capital"
    }
  ],
  "position_analysis": {
    "target_per_position": "8-15% return per winning trade",
    "diversification": "5 positions + 10% cash",
    "risk_per_position": "Max 2% portfolio risk per trade",
    "win_rate_needed": "3 out of 5 positions profitable",
    "realistic_scenario": "60% win rate with avg 12% per winner"
  },
  "risk_assessment": {
    "success_probability": "40-60% (much better than 43% target)",
    "expected_return": "6-14% range",
    "max_drawdown": "15-25% worst case",
    "time_decay_risk": "Moderate - using 30-45 DTE options",
    "market_risk": "Moderate - earnings season catalyst dependent"
  },
  "execution_plan": {
    "week_1": "Enter MSFT, GOOGL positions before earnings",
    "week_2": "Add AMD, QQQ on any dips",
    "week_3": "SPY weekly plays based on Fed/economic data",
    "week_4": "Profit taking and position management"
  },
  "wsb_sentiment_moderate": {
    "quality_plays": [
      "MSFT",
      "GOOGL",
      "AMD",
      "QQQ"
    ],
    "earnings_focus": "Big tech Q4 results",
    "avoid_still": [
      "Meme stocks",
      "0DTE plays",
      "Small cap biotechs"
    ]
  }
}